FDA NDC Directory · JSON-LD · Markdown

FYARRO

NDC 80803-153 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Generic nameSirolimus
Labeler / ManufacturerAadi Bioscience, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA213312
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · INTRAVENOUS
Active ingredientsSIROLIMUS (5 mg/mL)
Marketing started20211206
Package count1

External sources

Source: openFDA. Public-domain (CC0).